HCSG COO reports equity vesting and tax share withholding

Healthcare Services Group EVP & COO Andrew Kush reported equity award activity tied to prior grants.

Rhea-AI Filing Summary

Healthcare Services Group EVP & COO Andrew Kush reported equity award activity tied to prior grants. On February 24, 2026, 4,416 restricted stock units were converted into common stock, and 12,618 shares of common stock were issued at a 1-for-1 conversion rate.

The common shares reflect performance stock units granted in February 2023 that vested after financial goals through December 31, 2025 were certified. To cover related tax obligations, 1,874 and 5,353 common shares were withheld at $21.40 per share, leaving Kush with 38,339 directly owned common shares.

Insider Trade Summary

4,416 shares exercised/converted

Exercise 5 txns

Insider Kush Andrew

Role EVP & Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,416	$0.00	$0.00
Exercise	Common Stock	4,416	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,874	$21.40	$40K
Exercise	Common Stock	12,618	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	5,353	$21.40	$115K

Holdings After Transaction: Restricted Stock Units — 8,830 contracts (Direct); Common Stock — 38,339 shares (Direct)

Footnotes (4)

1. F1. Represents shares withheld to pay taxes.
2. F2. Represents common stock earned and delivered on a performance stock unit award previously granted in February 2023, based on the satisfaction of certain financial performance criteria for the period ended December 31, 2025. The Company's Nominating, Compensation and Stock Option Committee certified the level of performance-goal attainment on February 24, 2026 and the shares vested upon certification.
3. F3. Shares issued at the conversion rate of 1-for-1.
4. F4. These Restricted Stock Units shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HCSG executive Andrew Kush report on this Form 4?

Andrew Kush reported equity award activity, including conversions of restricted and performance stock units into common stock and share withholdings for taxes. These transactions reflect vesting of prior grants rather than open-market buying or selling of Healthcare Services Group (HCSG) stock.

How many HCSG shares did Andrew Kush receive from equity awards vesting?

Andrew Kush received 4,416 shares of common stock from restricted stock units and 12,618 shares from performance stock units. Both awards were previously granted, with the performance units vesting after financial goals through December 31, 2025 were certified by the company’s compensation committee.

Were any of Andrew Kush’s HCSG shares sold on the open market in this filing?

The Form 4 shows no open-market sales. Instead, 1,874 and 5,353 common shares were withheld at $21.40 per share to satisfy tax obligations associated with the vesting and conversion of equity awards granted to Andrew Kush by Healthcare Services Group.

What performance period was tied to Andrew Kush’s HCSG performance stock units?

The performance stock units were granted in February 2023 and were tied to financial performance criteria for the period ending December 31, 2025. The compensation committee certified performance on February 24, 2026, triggering vesting and delivery of common shares to Andrew Kush.

What vesting schedule applies to Andrew Kush’s HCSG restricted stock units?

The restricted stock units granted on February 24, 2023 vest at a rate of 20% annually, beginning on the first anniversary of the grant date. This schedule means portions of the award become exercisable each year, providing ongoing equity-based compensation to Andrew Kush over multiple years.

How many HCSG common shares does Andrew Kush directly own after these transactions?

After the reported transactions, Andrew Kush directly owns 38,339 shares of Healthcare Services Group common stock. This figure reflects shares acquired from equity award conversions, net of shares withheld to cover related tax obligations, as detailed in the Form 4 insider transaction report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kush Andrew

(Last) (First) (Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM PA 19020

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		4,416	A	$0	32,948	D
Common Stock	02/24/2026		F		1,874(1)	D	$21.4	31,074	D
Common Stock	02/24/2026		M		12,618(2)	A	$0	43,692	D
Common Stock	02/24/2026		F		5,353(1)	D	$21.4	38,339	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	02/24/2026		M			4,416	(4)	(4)	Common Stock	4,416	$0	8,830	D

Explanation of Responses:

1. Represents shares withheld to pay taxes.

2. Represents common stock earned and delivered on a performance stock unit award previously granted in February 2023, based on the satisfaction of certain financial performance criteria for the period ended December 31, 2025. The Company's Nominating, Compensation and Stock Option Committee certified the level of performance-goal attainment on February 24, 2026 and the shares vested upon certification.

3. Shares issued at the conversion rate of 1-for-1.

4. These Restricted Stock Units shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.

Remarks:

	Michael Harrity, by Power of Attorney	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.